News

The Phase III trial met its primary endpoint and showed that the combination therapy helped these patients live significantly longer without their disease worsening (progression-free survival; PFS) compared

The study is on track with Genticel’s initial projections. All of the 39 investigation sites across seven European countries (Belgium, Finland, France, Germany, the Netherlands, Spain and the

The results show overall efficacy against symptomatic dengue of 56.5% in children aged two to 14 years old after a three-dose vaccination schedule. A total of 10,275 children

Archimedes Pharma is a UK-based pharmaceutical firm that provides treatments within the therapeutic areas of pain, oncology and critical care. PecFent, Archimedes’ fentanyl nasal spray, is used in

HinsBet is a new type of prandial insulin, developed using the Company’s proprietary BioChaperone technology, that has been designed to reconcile the performance of insulin analogs with the

Marc de Garidel, Chairman and Chief Executive Officer of Ipsen stated: "We are delighted to expand and deepen our collaboration with Galderma, based on our common ambition to

The terms of the placement are for the purchase of common shares at $1.60 per share and include one warrant per share at an exercise price of $2.24

Actavis’ ANDA product is a generic version of Duchesnay Inc.’s Diclegis, which is indicated for the treatment of nausea and vomiting of pregnancy in women who do not

With these latest grants, BrightFocus has now provided more than $8.7 million in research funding in 2014. The research projects funded this year reflect a range of study